NO984476L - Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene - Google Patents
Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelseneInfo
- Publication number
- NO984476L NO984476L NO984476A NO984476A NO984476L NO 984476 L NO984476 L NO 984476L NO 984476 A NO984476 A NO 984476A NO 984476 A NO984476 A NO 984476A NO 984476 L NO984476 L NO 984476L
- Authority
- NO
- Norway
- Prior art keywords
- sulfonamide
- medicament
- compounds
- processes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19742508A DE19742508A1 (de) | 1997-09-26 | 1997-09-26 | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO984476D0 NO984476D0 (no) | 1998-09-25 |
| NO984476L true NO984476L (no) | 1999-03-29 |
Family
ID=7843708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO984476A NO984476L (no) | 1997-09-26 | 1998-09-25 | Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6177449B1 (tr) |
| EP (1) | EP0906911B1 (tr) |
| JP (1) | JP4422222B2 (tr) |
| KR (1) | KR19990030120A (tr) |
| CN (1) | CN1216763A (tr) |
| AR (1) | AR014915A1 (tr) |
| AT (1) | ATE265445T1 (tr) |
| AU (1) | AU755735B2 (tr) |
| BR (1) | BR9803367A (tr) |
| CA (1) | CA2248300C (tr) |
| CZ (1) | CZ307198A3 (tr) |
| DE (2) | DE19742508A1 (tr) |
| ES (1) | ES2221107T3 (tr) |
| HR (1) | HRP980528A2 (tr) |
| HU (1) | HUP9802155A3 (tr) |
| ID (1) | ID20967A (tr) |
| IL (1) | IL126280A (tr) |
| NO (1) | NO984476L (tr) |
| NZ (1) | NZ332030A (tr) |
| PL (1) | PL328854A1 (tr) |
| RU (1) | RU2220965C2 (tr) |
| SK (1) | SK131898A3 (tr) |
| TR (1) | TR199801903A3 (tr) |
| TW (1) | TW565559B (tr) |
| ZA (1) | ZA988788B (tr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19748469A1 (de) * | 1997-11-03 | 1999-05-06 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE19858253A1 (de) * | 1998-12-17 | 2000-06-21 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden |
| TW589305B (en) | 2001-02-14 | 2004-06-01 | Nissan Chemical Ind Ltd | 4-aminobenzopyran derivatives |
| FI20011507A0 (fi) * | 2001-07-10 | 2001-07-10 | Orion Corp | Uusia yhdisteitä |
| US7001660B2 (en) * | 2001-07-16 | 2006-02-21 | Gilbert Garitano | Images in solids surfaces |
| FI20030030A0 (fi) * | 2003-01-09 | 2003-01-09 | Orion Corp | Uusia yhdisteitä |
| US7368582B2 (en) | 2003-10-17 | 2008-05-06 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them |
| MY147767A (en) * | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| US7714150B2 (en) | 2005-04-12 | 2010-05-11 | Solvay Pharmaceuticals Gmbh | Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives |
| CN101160301B (zh) * | 2005-04-12 | 2012-03-28 | 索尔瓦药物有限公司 | 氨基烷基-酰胺基甲基-取代的2-(4-磺酰基氨基)-3-羟基-3,4-二氢-2h-色烯-6-基衍生物以及它们作为钾通道阻断剂的用途 |
| WO2010018867A1 (ja) * | 2008-08-14 | 2010-02-18 | 日産化学工業株式会社 | ジ置換ベンゾピラン化合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820834A (en) | 1984-06-26 | 1989-04-11 | Merck & Co., Inc. | Benzodiazepine analogs |
| FR2639349B1 (fr) * | 1988-11-23 | 1991-02-22 | Sanofi Sa | Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant |
| US5104890A (en) * | 1989-03-28 | 1992-04-14 | Fujisawa Pharmaceutical Company, Ltd. | Benzopyran derivatives and processes for preparation thereof |
| US5428031A (en) | 1991-12-03 | 1995-06-27 | Merck & Co., Inc. | Methods of treating cardiac arrhythmia |
| TW496866B (en) * | 1996-05-15 | 2002-08-01 | Hoechst Ag | Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or a diagnostic, and medicament comprising them |
| DE19706675A1 (de) * | 1997-02-20 | 1998-08-27 | Hoechst Ag | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19742509A1 (de) * | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
-
1997
- 1997-09-26 DE DE19742508A patent/DE19742508A1/de not_active Withdrawn
-
1998
- 1998-09-17 IL IL12628098A patent/IL126280A/xx not_active IP Right Cessation
- 1998-09-19 EP EP98117810A patent/EP0906911B1/de not_active Expired - Lifetime
- 1998-09-19 AT AT98117810T patent/ATE265445T1/de not_active IP Right Cessation
- 1998-09-19 DE DE59811267T patent/DE59811267D1/de not_active Expired - Lifetime
- 1998-09-19 ES ES98117810T patent/ES2221107T3/es not_active Expired - Lifetime
- 1998-09-22 CA CA002248300A patent/CA2248300C/en not_active Expired - Fee Related
- 1998-09-22 CN CN98119539A patent/CN1216763A/zh active Pending
- 1998-09-24 TR TR1998/01903A patent/TR199801903A3/tr unknown
- 1998-09-24 RU RU98117567/04A patent/RU2220965C2/ru not_active IP Right Cessation
- 1998-09-24 SK SK1318-98A patent/SK131898A3/sk unknown
- 1998-09-24 NZ NZ332030A patent/NZ332030A/xx unknown
- 1998-09-24 CZ CZ983071A patent/CZ307198A3/cs unknown
- 1998-09-24 ID IDP981279A patent/ID20967A/id unknown
- 1998-09-24 AR ARP980104775A patent/AR014915A1/es not_active Application Discontinuation
- 1998-09-25 JP JP27216898A patent/JP4422222B2/ja not_active Expired - Fee Related
- 1998-09-25 HU HU9802155A patent/HUP9802155A3/hu unknown
- 1998-09-25 AU AU87082/98A patent/AU755735B2/en not_active Ceased
- 1998-09-25 HR HR19742508.9A patent/HRP980528A2/hr not_active Application Discontinuation
- 1998-09-25 BR BR9803367-0A patent/BR9803367A/pt not_active IP Right Cessation
- 1998-09-25 PL PL98328854A patent/PL328854A1/xx unknown
- 1998-09-25 KR KR1019980039836A patent/KR19990030120A/ko not_active Application Discontinuation
- 1998-09-25 NO NO984476A patent/NO984476L/no not_active Application Discontinuation
- 1998-09-25 ZA ZA988788A patent/ZA988788B/xx unknown
- 1998-10-22 TW TW087115865A patent/TW565559B/zh active
-
1999
- 1999-10-20 US US09/421,277 patent/US6177449B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR19990030120A (ko) | 1999-04-26 |
| SK131898A3 (en) | 1999-06-11 |
| CA2248300A1 (en) | 1999-03-26 |
| RU2220965C2 (ru) | 2004-01-10 |
| NO984476D0 (no) | 1998-09-25 |
| PL328854A1 (en) | 1999-03-29 |
| IL126280A0 (en) | 1999-05-09 |
| CA2248300C (en) | 2008-12-02 |
| HU9802155D0 (en) | 1998-11-30 |
| DE19742508A1 (de) | 1999-04-01 |
| NZ332030A (en) | 2000-04-28 |
| AR014915A1 (es) | 2001-04-11 |
| AU755735B2 (en) | 2002-12-19 |
| ZA988788B (en) | 1999-03-26 |
| HUP9802155A2 (hu) | 1999-09-28 |
| TR199801903A2 (tr) | 1999-04-21 |
| CN1216763A (zh) | 1999-05-19 |
| ID20967A (id) | 1999-04-01 |
| HRP980528A2 (en) | 1999-06-30 |
| EP0906911B1 (de) | 2004-04-28 |
| IL126280A (en) | 2003-10-31 |
| US6177449B1 (en) | 2001-01-23 |
| JPH11158171A (ja) | 1999-06-15 |
| HUP9802155A3 (en) | 2002-04-29 |
| JP4422222B2 (ja) | 2010-02-24 |
| ES2221107T3 (es) | 2004-12-16 |
| DE59811267D1 (de) | 2004-06-03 |
| ATE265445T1 (de) | 2004-05-15 |
| EP0906911A1 (de) | 1999-04-07 |
| AU8708298A (en) | 1999-04-15 |
| TW565559B (en) | 2003-12-11 |
| BR9803367A (pt) | 2000-05-09 |
| TR199801903A3 (tr) | 1999-04-21 |
| CZ307198A3 (cs) | 1999-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1194403T3 (da) | Indanylsubstituerede benzencarboxamider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel samt farmaceutiske tilberedninger med indhold deraf | |
| NO20032735L (no) | Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse | |
| NO972211D0 (no) | Sulfonamid-substituerte kromaner, deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende kromanene | |
| NO973923D0 (no) | Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene | |
| NO20032187L (no) | Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene | |
| NO20021398D0 (no) | 2'-substituerte 1,1'-bifenyl-2-karbonamider, fremgangsmåte for fremstilling, deres anvendelse som medikament såvel somfarmasöytiske preparater inneholdende disse | |
| NO980273D0 (no) | Femleddede heterocykluser med bifenylsulfonylsubstitusjon fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
| NO984476D0 (no) | Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene | |
| NO20016247L (no) | Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene | |
| NO972433D0 (no) | Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
| BR9811582B1 (pt) | compostos derivados de 4-oxo-3,5-di-hidro-4h-piridazino[4,5-b]indol-1-acetamid a, medicamento e composição farmacêutica contendo os mesmos. | |
| NO960364D0 (no) | Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
| NO20022801D0 (no) | Substituerte norbornylaminoderivater, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikumsåvel som medikamenter inneholdende disse | |
| NO985023D0 (no) | Sulfonamidsubstituerte benzopyranderivater, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene | |
| DK1118610T3 (da) | Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne | |
| NO974563D0 (no) | Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene | |
| NO964053D0 (no) | Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
| NO984475D0 (no) | Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene | |
| NO985171D0 (no) | Sulfonamidsubstituerte kondenserte 5-ringforbindelser, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene | |
| NO980785D0 (no) | Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene | |
| NO983577L (no) | Sulfonamidsubstituerte forbindelser, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament eller diagnostikum, samt medikament inneholdende forbindelsen | |
| NO972434L (no) | Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene | |
| DK1036090T3 (da) | Echinocandinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som antifungale midler | |
| DK225189D0 (da) | Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler | |
| NO980564D0 (no) | Sulfonamid-substituerte forbindelser, fremgangsmåte for fremstilling, anvendelse som medikament eller diagnostikum samt oppnådd medikament er beskrevet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |